Developing ADCs of tomorrow
Location: Denmark, Capital Region of Denmark, Copenhagen
Total raised: $209.36M
Investors 2
| Date | Name | Website |
| - | RA Capital... | racap.com |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 04.04.2023 | Series A | $89.55M | - |
| 12.01.2022 | Series A | $57.95M | - |
| 29.04.2021 | Series A | $61.86M | Novo Holdi... |
Mentions in press and media 15
| Date | Title | Description | Source |
| 14.04.2023 | Adcendo ApS to Present Data on the Expression of the Novel A... | Copenhagen, Denmark, 13 April, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the deve... | healthcap.... |
| 04.04.2023 | Adcendo ApS Announces Extension of Series A financing to 82M... | Copenhagen, Denmark, April 4th, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the dev... | healthcap.... |
| 04.04.2023 | Adcendo ApS Announces Extension of Series A Financing to 82M... | Series A Financing extension led by Pontifax Venture Capital and existing investors Novo Holdings an... | einpresswi... |
| 04.04.2023 | Adcendo Raises €31M; Extends Series A Round to €82M | Adcendo ApS, a Copenhagen, Denmark-based biotech company focused on the development of antibody-drug... | finsmes.co... |
| 04.04.2023 | Over DKK 3 billion (USD 413 million) raised by BioInnovation... | Portfolio company Adcendo Aps, today announces extension of Series A financing to 82M EUR. BII publi... | einpresswi... |
| 04.04.2023 | Ysios Capital’s portfolio company Adcendo announces extensio... | 04/04/2023 Nota de prensa YSIOS CAPITAL’S PORTFOLIO COMPANY ADCENDO ANNOUNCES EXTENSION OF SERIES ... | webcapital... |
| 05.01.2023 | Adcendo ApS Announces License Agreement with Duality Biologi... | Copenhagen, Denmark, January 5, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the dev... | healthcap.... |
| 12.01.2022 | Adcendo Appoints Michael Pehl as Chief Executive Officer | • Experienced Industry Leader with successful Oncology, Immunotherapy & ADC Development Track Re... | healthcap.... |
| 12.01.2022 | Adcendo Further Strengthens Management Team and Scientific A... | Copenhagen, Denmark, December 1st, 2021 – Adcendo, a biotech company focused on the development of b... | healthcap.... |
| 29.04.2021 | Ysios Capital lidera una inversión de €51 millones en Adcend... | 29/04/2021 Nota de prensa YSIOS CAPITAL LIDERA UNA INVERSIÓN DE €51 MILLONES EN ADCENDO. − Adcend... | webcapital... |
Show more